# Classification of Two Steroids, Prostanozol and Methasterone, as Schedule III Anabolic Steroids Under the Controlled Substances Act
> **Proposed Rule** · Notice of proposed rulemaking. · Published 2011-11-23 · 76 FR 72355
## Document
- **Document number:** 2011-30081
- **Category:** other
- **Type:** Proposed Rule
- **Action:** Notice of proposed rulemaking.
- **Citation:** 76 FR 72355
- **Publication date:** 2011-11-23
## Abstract

This Notice of Proposed Rulemaking (NPRM) proposes to classify the following two steroids as "anabolic steroids" under the Controlled Substances Act (CSA): prostanozol (17[beta]-hydroxy- 5[alpha]-androstano[3,2-c]pyrazole) and methasterone (2[alpha],17[alpha]-dimethyl-5[alpha]-androstan-17[beta]-ol-3-one). The Drug Enforcement Administration (DEA) believes that this action is necessary to prevent the abuse and trafficking of these steroids. If the regulations are amended, these steroids will be listed as Schedule III controlled substances subject to the regulatory control provisions of the CSA.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2011/11/23/2011-30081/classification-of-two-steroids-prostanozol-and-methasterone-as-schedule-iii-anabolic-steroids-under)
---
*AI Analytics · CC0 1.0*